| (USD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.90M | — |
| Operating expense | — | — |
| Net income | -20.70M | -22.69% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KZIA returned +73.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +94.6% |
| 1 year | +73.9% |
| 5 years | -97.5% |
| 10 years | -96.7% |
| All-time high | $8,986.17 (Dec 2003) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KZIA would be worth today ›No. Kazia Therapeutics Limited has not paid a dividend in the past 12 months.
Kazia Therapeutics Limited stock trades on NASDAQ under the ticker symbol KZIA.
Kazia Therapeutics Limited is part of the Healthcare sector.
Kazia Therapeutics Limited has a market cap of 153.18M USD, based on the latest quote.